Login / Signup
Bo-Mi Kim
ORCID
Publication Activity (10 Years)
Years Active: 2018-2021
Publications (10 Years): 3
Top Topics
Regulatory T Cells
Dendritic Cells
Clinical Trial
Chronic Lymphocytic Leukemia
Top Venues
Immune network
Stem cells international
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Tae Hyun Ban
,
Sua Lee
,
Hyung Duk Kim
,
Eun Jeong Ko
,
Bo-Mi Kim
,
Kyoung-Woon Kim
,
Byung Ha Chung
,
Chul Woo Yang
Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin.
Stem cells international
2021 (2021)
Kyoung-Woon Kim
,
Hae-Rim Kim
,
Bo-Mi Kim
,
Ji-Yeon Won
,
Kyung-Ann Lee
,
Sang-Heon Lee
Intravenous Immunoglobulin Controls Th17 Cell-Mediated Osteoclastogenesis.
Immune network
19 (4) (2019)
Yu Ho Lee
,
Jung-Woo Seo
,
Yang-Gyun Kim
,
Ju Young Moon
,
Jin Sug Kim
,
Kyung-Hwan Jeong
,
Bo-Mi Kim
,
Kyoung-Woon Kim
,
Chul Woo Yang
,
Chan Duck Kim
,
Jae Berm Park
,
Yeong Hoon Kim
,
Byung Ha Chung
,
Sang Ho Lee
Validation Study of an Operational Tolerance Signature in Korean Kidney Transplant Recipients.
Immune network
18 (5) (2018)